Overview
China aesthetic treatment platform's Q1 revenue rose yr/yr, driven by branded center expansion
Company's net loss widened from a year ago as operating expenses increased
Aesthetic treatment services revenue more than doubled, offsetting declines in other segments
Outlook
So-Young expects Q2 2026 aesthetic treatment services revenue of RMB307 mln to RMB317 mln
Result Drivers
CENTER EXPANSION - Co said revenue growth was mainly due to business expansion of branded aesthetic centers
CORE MEMBER CONTRIBUTION - Core members accounted for over 80% of aesthetic treatment services revenue with a quarterly repurchase rate nearly 80%
DECLINE IN PLATFORM SERVICES - Information and reservation services revenue fell due to fewer medical service providers subscribing to platform
Company press release: ID:nPn9p7ddna
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
RMB 432.78 mln
Q1 Net Income
-RMB 49.2 mln
Q1 Gross Profit
RMB 181.78 mln
Q1 Income from Operations
-RMB 57.89 mln
Q1 Operating Expenses
RMB 239.67 mln
Q1 Pretax Profit
-RMB 50.96 mln
Analyst Coverage
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the miscellaneous specialty retailers peer group is "buy."
Wall Street's median 12-month price target for So-Young International Inc is $7.50, about 180.9% above its May 21 closing price of $2.67
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)